Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Abbott Laboratories
IndexS&P 500 P/E30.73 EPS (ttm)1.39 Insider Own0.10% Shs Outstand1.50B Perf Week-0.21%
Market Cap64.24B Forward P/E17.34 EPS next Y2.46 Insider Trans5.18% Shs Float1.50B Perf Month0.92%
Income2.16B PEG2.90 EPS next Q0.59 Inst Own69.10% Short Float0.82% Perf Quarter7.63%
Sales21.82B P/S2.94 EPS this Y319.40% Inst Trans-0.18% Short Ratio2.52 Perf Half Y9.34%
Book/sh15.67 P/B2.73 EPS next Y10.59% ROA5.60% Target Price44.14 Perf Year25.13%
Cash/sh4.70 P/C9.10 EPS next 5Y10.60% ROE10.00% 52W Range32.07 - 43.27 Perf YTD13.35%
Dividend0.88 P/FCF54.62 EPS past 5Y-13.00% ROI8.00% 52W High-0.87% Beta0.61
Dividend %2.06% Quick Ratio1.60 Sales past 5Y-5.80% Gross Margin54.30% 52W Low33.76% ATR0.48
Employees69000 Current Ratio1.90 Sales Q/Q1.90% Oper. Margin12.80% RSI (14)55.95 Volatility1.02% 1.09%
OptionableYes Debt/Eq0.29 EPS Q/Q0.00% Profit Margin11.00% Rel Volume0.51 Prev Close42.72
ShortableYes LT Debt/Eq0.14 EarningsOct 14 BMO Payout46.50% Avg Volume4.88M Price42.90
Recom2.30 SMA200.81% SMA501.54% SMA2009.02% Volume1,434,024 Change0.41%
17-Jul-14Reiterated Stifel Buy $42 → $47
17-Jul-14Reiterated Barclays Equal Weight $40 → $43
10-Mar-14Initiated Singular Research Sell $30
16-Dec-13Reiterated Deutsche Bank Hold $37 → $39
07-Oct-13Reiterated Stifel Buy $44 → $40
18-Jul-13Reiterated Barclays Equal Weight $35 → $37
28-May-13Reiterated RBC Capital Mkts Outperform $38 → $42
21-May-13Initiated Gabelli & Co Buy
19-Apr-13Reiterated RBC Capital Mkts Outperform $37 → $38
18-Apr-13Reiterated Stifel Buy $40 → $44
12-Apr-13Reiterated Deutsche Bank Hold $33 → $35
15-Feb-13Initiated Stifel Nicolaus Buy $40
11-Jan-13Reiterated UBS Buy $75 → $38
11-Jan-13Initiated Barclays Equal Weight $35
04-Jan-13Downgrade Deutsche Bank Buy → Hold $70 → $33
19-Jul-12Reiterated UBS Buy $68 → $72
19-Mar-12Reiterated UBS Buy $62 → $68
19-Mar-12Reiterated RBC Capital Mkts Outperform $60 → $68
09-Dec-11Downgrade Barclays Capital Overweight → Equal Weight $55 → $55
27-Oct-11Reiterated Deutsche Bank Hold $53 → $58
16-Sep-14 09:11AM  Abbott Included In Top 10 Best Companies by Working Mother Magazine PR Newswire
08:00AM  The Keys In This Market: Income & Growth at Forbes
15-Sep-14 07:20PM  New York Files Antitrust Suit Against Alzheimers Drug Maker at New York Times
07:20PM  New York Files an Antitrust Suit Against the Maker of an Alzheimers Drug at New York Times
04:20PM  Abbott Labs Presents Positive One-Year Data on Absorb Zacks
09:30AM  Abbott Initiates ABSORB IV Trial to Evaluate Quality of Life and Cost Savings of Dissolving Heart Device PR Newswire
07:52AM  Attunity, Ltd. (ATTU) in Focus: Stock Adds 5.2% in Session Zacks
14-Sep-14 11:00AM  ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent PR Newswire
11:00AM  Abbotts Dissolving Heart Stent Clears Arteries in Trial at Bloomberg
11:00AM  Abbott dissolving stent has lower angina rate vs metal stent -study Reuters
12-Sep-14 04:05PM  AbbVie's Humira Positive in Phase III Skin Disease Study Zacks
03:50PM  Abbott Labs (ABT) to Repurchase Shares for $3B Zacks
11-Sep-14 04:20PM  Mylan to Acquire U.S. Rights to Arixtra for up to $300M Zacks
02:48PM  [$$] Abbott Labs Sets $3 Billion Buyback at The Wall Street Journal
02:29PM  Abbott Laboratories (ABT) Declares Quarterly Dividend, Announces Share Buyback at TheStreet
02:09PM  [$$] Abbott Labs Approves $3 Billion in Buybacks at The Wall Street Journal
02:04PM  [$$] Abbott Labs Approves $3 Billion in Buybacks at The Wall Street Journal
01:39PM  Abbott Announces New $3 Billion Share Repurchase Program, Declares Dividend PR Newswire
10:44AM  Abbott Once Again Named the Industry Leader for Responsible and Sustainable Business on the Dow Jones Sustainability Index (DJSI) PR Newswire
10-Sep-14 10:06AM  [video] Sen. Schumer's inversion compromise at CNBC
08-Sep-14 03:35PM  [video] Pursuing tax inversion solutions at CNBC
02:53PM  FTC sues AbbVie, Teva over generic AndroGel AP
09:24AM  New Abbott Technology May Uncover the Root of Critical Infections and Cut Health Care Costs PR Newswire
05-Sep-14 03:35PM  Abbott Labs' FreeStyle Libre Flash Glucose Gets CE Mark Zacks
06:00AM  Abbott Labs' Weakness in Devices Hurts Long-Term Growth Potential at TheStreet
04-Sep-14 03:38PM  Google's Calico in $500M Joint Venture with AbbVie Zacks
02:38PM  [video] Diabetes monitoring goes mobile at CNBC
03-Sep-14 03:18PM  FDA: Little evidence to support testosterone drugs AP
01:03PM  3 Health Services Stocks Moving The Industry Upward at TheStreet
09:30AM  Abbott Receives CE Mark for FreeStyle┬« Libre, a Revolutionary Glucose Monitoring System for People with Diabetes PR Newswire
28-Aug-14 02:13PM  Abbott: A Brighter Future Gurufocus
10:38AM  [video] Santelli Exchange: Truth about inversions at CNBC
26-Aug-14 12:00AM  Boehner Joins Camp in Profiting From Corporate Effort to Escape U.S. Taxes Bloomberg
25-Aug-14 09:10AM  ABBOTT LABORATORIES Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online
09:00AM  Abbott Commences Tender Offer for All Outstanding Ordinary Shares and American Depositary Shares of CFR Pharmaceuticals S.A. PR Newswire
23-Aug-14 07:00AM  A Shift in Health-Care M&A Activity Morningstar
22-Aug-14 04:55PM  Johnson & Johnson vs. Abbott Laboratories in the Battle for Emerging Market Turf at TheStreet
19-Aug-14 06:27PM  This stock may be hazardous to your financial health Talking Numbers
10:45AM  You've got obesity all wrong: Zafgen CEO at CNBC
18-Aug-14 09:00AM  Abbott Joins Forces with U.S. Department of Defense to Develop Portable Blood Tests for Evaluating Concussions PR Newswire
15-Aug-14 07:02PM  Abbott, AbbVie Win Dismissal of Suit Over Depakote Marketing at Bloomberg
10:32AM  Do We Really Trust Corporations To Investigate Their Own Profitable Impropriety? at Forbes
12-Aug-14 01:04PM  ABBOTT LABORATORIES Financials EDGAR Online Financials
10:06AM  5 Companies That Have Moved Overseas For Lower Taxes Benzinga
09:30AM  Access to Abbott's MitraClip┬« System Expands in the U.S. with Medicare National Coverage Determination PR Newswire
08-Aug-14 07:15AM  Bet On This Top Ranked Medical Device ETF Zacks
07-Aug-14 10:15AM  Mylan Misses Q2 Earnings and Sales Estimates, Adjusts View Zacks
06-Aug-14 04:10PM  Will Mylan (MYL) Earnings in Q2 Disappoint Expectations? Zacks
05-Aug-14 04:36PM  Delamaide: Tax issue shows Congress' failure at USA TODAY
04:32PM  ABBOTT LABORATORIES Files SEC form 10-Q, Quarterly Report EDGAR Online
04:03PM  Delamaide: Tax issue shows Congress' failure at USA TODAY
04-Aug-14 08:50AM  [video] Cramer's stocks to watch: KORS at CNBC
01-Aug-14 12:01PM  Charles R. Kummeth, the President and CEO of Bio-Techne (TECH), Interviews with The Wall Street Transcript Wall Street Transcript
10:26AM  Can Obamacare case jump right to Supreme Court? at CNBC
31-Jul-14 06:07AM  Meda to Pay $3 Billion to Acquire Italian Drug Maker at New York Times
06:07AM  Meda to Pay $3 Billion to Acquire Italian Drug Maker Rottapharm at New York Times
06:07AM  Meda to Buy Italian Drug Maker Rottapharm for About $3 Billion at New York Times
28-Jul-14 02:41PM  How Obama Could End Walgreen's Tax-Inversion Hopes at Investor's Business Daily
01:04PM  3 Stocks Pushing The Health Services Industry Lower at TheStreet
01:00PM  Abbott to Showcase Innovations to Help Labs Solve Health Care Challenges at the American Association for Clinical Chemistry Lab Expo PR Newswire
27-Jul-14 03:44PM  Top Trade Ideas for the Week of July 28, 2014: The Rest Yahoo Finance Blogs
25-Jul-14 06:30AM  Obama calls on Congress to end inversion deals, NY Times reports at theflyonthewall.com
24-Jul-14 08:31PM  To Woo Shire, AbbVie Trod Cautiously in Takeover Bid at New York Times
02:50PM  Did Congress prescribe Obamacare a 'poison pill?' at CNBC
02:50PM  Did Congress mean to prescribe a 'poison pill'? at CNBC
08:00AM  Abbott Introduces New Similac┬« Breastfeeding Supplement with DHA, Lutein and Vitamin E PR Newswire
06:54AM  GlaxoSmithKline Slumps: GSK Falls 5.9% in Session Zacks
23-Jul-14 10:23AM  Who gets the last word on Obamacare? at CNBC
22-Jul-14 05:30PM  Dividend Growth Investing: An Open Portfolio For Your Review at Seeking Alpha
05:13PM  A DGI Portfolio: Case For Passive Income From Stock Dividends - Part 3 at Seeking Alpha
01:32PM  India's new government vows clampdown on healthcare graft Reuters
08:45AM  MYOS Corp. Tackles Muscles Health at Seeking Alpha
05:00AM  Where Are the Best 401(k)s? Retire at 60 at Conoco With $3.8 Million; Facebook Last Bloomberg
05:00AM  ConocoPhillips Best Among 401(k) Plans With Facebook Last Bloomberg
05:00AM  ConocoPhillips Best Among 401(k) Plans With Facebook Last at Bloomberg
21-Jul-14 09:33AM  AbbVie Gets Its 'Tax Break' In Shire at Seeking Alpha
09:17AM  Will These EPS Estimate Cuts Hurt Abbott Laboratories (ABT) Stock Today? at TheStreet
02:56AM  Why Abbott's Stake In Mylan Will Be Value-Creative at Seeking Alpha
20-Jul-14 05:02PM  Can Abbott Laboratories Stock Continue to Impress? at Motley Fool
18-Jul-14 05:16PM  [video] Pharma inversion deals at CNBC
04:02PM  Why Growth Is Coming to Abbott Laboratories Stock at Motley Fool
12:51PM  Key GOP senator signals readiness for inversion deal, The Hill says theflyonthewall.com
11:25AM  Heres the sad truth about tax-inversion deals at MarketWatch
10:43AM  America Just Lost Another Billion-Dollar Company To Ireland Business Insider
08:33AM  Drugmakers announce tax-cutting merger at CNNMoney.com
17-Jul-14 04:33PM  [video] U.S. Markets Close Sharply Lower on Geopolitical Uncertainty at TheStreet
02:48PM  Abbott investors' delayed reaction: Shares jump a day after earnings at MarketWatch
12:06AM  Abbott Laboratories Declared Its 362nd Quarterly Dividend, But Earnings Were Mediocre at Seeking Alpha
16-Jul-14 06:23PM  Congress And Tax Inversions: A Wall Streeter's Take On 2014 at Forbes
06:10PM  Abbott, St. Jude Top Views, But Stocks Under Pressure at Investor's Business Daily
05:02PM  Abbott Labs Stock Earnings: Why Steady Isn't Enough at Motley Fool
05:02PM  New Evidence Fuels Concerns About The Safety Of Niacin at Forbes
04:05PM  Abbott Asset Sale Gives Ammunition for Perrigo: Real M&A at Bloomberg
03:50PM  [video]Abbott Labs Gets No Respect Despite a Healthy Second Quarter at TheStreet
03:28PM  Treasury Urges Halt to Tax Inversion M&A 'Abuse' at Investor's Business Daily
03:19PM  A Navy Nurse Is Refusing to Force-Feed a Guantanamo Inmate at BusinessWeek
02:13PM  Abbott Laboratories' (ABT) CEO, Miles White on Q2 2014 Results - Earnings Call Transcript Seeking Alpha
01:58PM  St. Jude, Abbott Labs Earnings Beat Q2 Estimates at Investor's Business Daily
01:19PM  [video] Abbott Laboratories Q2 Beat On Improved Medical Diagnostics Sales at TheStreet
01:02PM  Midday movers: Abbott, Northern Trust, Tesla & More at CNBC
Abbott Laboratories manufactures and sells health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome, intrahepatic cholestasis or depressive symptoms, gynecological disorders, dyslipidemia, hypertension, hypothyroidism, pain, fever, and inflammation; and regulates physiological rhythm of the colon, as well as provides hormone replacement therapy and anti-infective and influenza vaccines. The company's Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; hematology systems and reagents; genomic-based tests; informatics and automation solutions; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products, such as various forms of prepared infant and follow-on formula. The company's Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular diseases. Abbott Laboratories also offers blood glucose and glucose monitoring systems, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, such as cataract surgery, LASIK surgery, and contact lens care and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. It has strategic alliance with Fonterra Co-operative Group Ltd. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
FREYMAN THOMAS CExecutive Vice PresidentJul 21Option Exercise24.0779,0001,901,828390,326Jul 22 05:03 PM
Landgraf John CExecutive Vice PresidentJun 03Option Exercise31.9118,203580,771113,334Jun 05 05:09 PM
Blaser Brian JExecutive Vice PresidentMar 03Sale39.011,44156,219102,895Mar 04 05:07 PM
Mason Heather LSenior Vice PresidentMar 03Sale38.952,19685,540118,410Mar 04 05:07 PM
Funck Robert EVice President, ControllerMar 03Sale38.971,41355,06862,926Mar 04 05:05 PM
ALLEN HUBERT LExecutive Vice PresidentMar 03Sale39.031,54360,22952,525Mar 04 05:06 PM
Foltz Charles DSenior Vice PresidentMar 03Sale38.951,58861,85465,318Mar 04 05:06 PM
ASHLEY RICHARD WExecutive Vice PresidentMar 03Sale39.002,09881,829333,072Mar 04 05:06 PM
Warmuth Michael JExecutive Vice PresidentMar 03Sale39.0116,484642,96615,851Mar 04 05:04 PM
Contreras JaimeSenior Vice PresidentMar 03Sale39.378,081318,16030,136Mar 04 05:05 PM
FREYMAN THOMAS CExecutive Vice PresidentMar 03Sale39.102,984116,686311,326Mar 04 05:05 PM
Landgraf John CExecutive Vice PresidentMar 03Sale39.3817,293681,05795,131Mar 04 05:04 PM
Doyle Katherine C.Senior Vice PresidentMar 03Sale39.016,639258,96447,525Mar 04 05:04 PM
Landgraf John CExecutive Vice PresidentFeb 18Option Exercise35.031,58355,452104,004Feb 19 06:54 PM
Contreras JaimeSenior Vice PresidentFeb 18Sale38.9662124,1911,067Feb 19 06:53 PM
Pavee Jean-YvesSenior Vice PresidentFeb 18Sale38.9748919,05429,479Feb 19 05:06 PM
ALLEN HUBERT LExecutive Vice PresidentFeb 18Sale39.0733313,00941,033Feb 19 05:06 PM
Landgraf John CExecutive Vice PresidentFeb 18Sale39.101,58361,899102,421Feb 19 06:54 PM
Landgraf John CExecutive Vice PresidentFeb 07Option Exercise32.1621,972706,529124,393Feb 11 05:05 PM
Landgraf John CExecutive Vice PresidentFeb 07Sale36.9621,972811,981102,421Feb 11 05:05 PM
Funck Robert EVice President, ControllerJan 31Option Exercise33.569,398315,40469,626Feb 04 05:02 PM
Funck Robert EVice President, ControllerJan 31Sale36.209,398340,19460,228Feb 04 05:02 PM
Warmuth Michael JExecutive Vice PresidentJan 29Option Exercise31.9111,430364,68451,917Jan 31 05:01 PM
Warmuth Michael JExecutive Vice PresidentJan 29Sale36.2111,430413,83240,487Jan 31 05:01 PM
Pavee Jean-YvesSenior Vice PresidentDec 06Option Exercise25.075,855146,80436,756Dec 10 05:05 PM
Pavee Jean-YvesSenior Vice PresidentDec 06Sale37.465,855219,29930,901Dec 10 05:05 PM
Foltz Charles DSenior Vice PresidentDec 05Option Exercise24.732,03050,19255,978Dec 09 05:25 PM
Foltz Charles DSenior Vice PresidentDec 05Sale37.031,71663,53554,262Dec 09 05:25 PM
WHITE MILES DChairman and CEONov 22Option Exercise33.37300,40110,024,3811,689,653Nov 26 05:14 PM
WHITE MILES DChairman and CEONov 22Sale38.12150,5275,738,4371,539,126Nov 26 05:14 PM
WHITE MILES DChairman and CEONov 22Sale38.26149,8745,734,0961,389,252Nov 26 05:14 PM
Fussell Stephen RExecutive Vice PresidentNov 08Option Exercise19.721,22724,192101,811Nov 08 05:08 PM
Fussell Stephen RExecutive Vice PresidentNov 07Option Exercise25.2710,466264,492111,050Nov 08 05:08 PM
Fussell Stephen RExecutive Vice PresidentNov 07Sale37.5910,466393,417100,584Nov 08 05:08 PM
Contreras JaimeSenior Vice PresidentOct 30Option Exercise35.082,71595,2424,781Nov 01 05:04 PM
Contreras JaimeSenior Vice PresidentOct 30Option Exercise33.4922,653758,57346,386Nov 01 05:04 PM
Contreras JaimeSenior Vice PresidentOct 30Sale37.012,715100,4852,066Nov 01 05:04 PM
Contreras JaimeSenior Vice PresidentOct 30Sale36.8322,653834,23123,733Nov 01 05:04 PM
FREYMAN THOMAS CExecutive Vice PresidentOct 21Option Exercise34.9342,4871,484,071350,283Oct 23 05:09 PM